Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record.

Current Management of Medullary Thyroid Cancer

Open access
Sippel, Rebecca S., Kunnimalaiyaan, Muthusamy, Chen, Herbert·2008·The Oncologist

Abstract

Learning Objectives: After completing this course, the reader will be able to: Evaluate a patient with a new diagnosis of medullary thyroid cancer.Use genetic testing for the ret proto-oncogene and assess how the location of the mutation affects the risks for the patient.Select among the surgical treatment options for patients with medullary thyroid cancer, including the optimal surgical treatment for patients with palpable disease as well as those patients who are found to be genetic carriers. CME This article is available for continuing medical education credit at CME.TheOncologist.com Medullary thyroid cancer accounts for 5%–10% of all thyroid cancers. The majority of medullary thyroid cancers are sporadic, but 20% of cases are a result of a germline mutation in the ret proto-oncogene. Hereditary medullary thyroid cancer can be seen as part of the multiple endocrine neoplasia syndrome type 2A or 2B or as part of familial medullary thyroid cancer. This article discusses the current methods available for the diagnosis and evaluation of a patient with suspected medullary thyroid cancer. The management of medullary thyroid cancer is predominantly surgical excision, consisting of a total thyroidectomy and lymph node dissection. The extent and timing of surgical excision are discussed. Systemic therapeutic options are limited for medullary thyroid cancer, but several therapeutic targets show promise for the development of new therapies in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.2007-0239

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
Sippel, R. S., Kunnimalaiyaan, M., & Chen, H.
Venue
The Oncologist
Published
2008-05-01
Volume
13
Issue
5
Pages
539-547
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2113328339
Cited by
181
References
0
FWCI
8.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Management of Medullary Thyroid Cancer. https://app.cochat.ai/papers/10.1634/theoncologist.2007-0239
The paper
Sippel, R. S., Kunnimalaiyaan, M., & Chen, H. (2008). Current Management of Medullary Thyroid Cancer. The Oncologist. https://doi.org/10.1634/theoncologist.2007-0239

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.